Skip to the content
NeuroDex – Biomarkers for Neurological Disorderslogo darklogo light
  • Home
  • About Us
    • Our Team
    • Our Labs
  • Our Tech
    • ExoSort Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • Pre-Clinical Services
    • Clinical Trial Services
  • Pressroom
    • NeuroDex News
    • Biotech Blog
    • Explanation Material
    • White Papers
    • Neurodex Brochures
  • Contact Us

More results...

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

NeuroDex – Biomarkers for Neurological Disorderslogo darklogo light
HomePosted by Victoria Akhiezer
What Is a Blood Test for Alzheimer’s? A Complete 2026 Guide
Explanation Material

What Is a Blood Test for Alzheimer’s? A Complete 2026 Guide

Victoria Akhiezer
July 17, 2026
NeuroDex Publishes Validated Workflow for Isolating Tissue-Specific Extracellular Vesicles From Blood
NeuroDex News

NeuroDex Publishes Validated Workflow for Isolating Tissue-Specific Extracellular Vesicles From Blood

Victoria Akhiezer
July 14, 2026
TDP-43 Proteinopathy
Explanation Material

TDP-43 Proteinopathy

Victoria Akhiezer
July 13, 2026
NeuroDex ExoSORT™ Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS
NeuroDex News

NeuroDex ExoSORT™ Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS

Victoria Akhiezer
July 1, 2026
Your End-to-End Partner for the Isolation and Profiling of Neuron-Derived Extracellular Vesicles (NDEVs)
Biotech Blog

Your End-to-End Partner for the Isolation and Profiling of Neuron-Derived Extracellular Vesicles (NDEs)

Victoria Akhiezer
June 19, 2026
The ALS Clinical Trials Landscape in 2026
Biotech Blog

The ALS Clinical Trials Landscape in 2026

Victoria Akhiezer
June 17, 2026
ELLA™ Neurofilament Light Chain (NF-L) Immunoassay
White Papers

ELLA™ Neurofilament Light Chain (NF-L) Immunoassay

Victoria Akhiezer
May 13, 2026
Blood Biomarkers for Rare Neurological Diseases
Explanation Material

Blood Biomarkers for Rare Neurological Diseases

Victoria Akhiezer
May 1, 2026
CSF Sampling Doesn’t Scale: The Case for Blood-Based CNS Biomarkers
Biotech Blog

CSF Sampling Doesn’t Scale: The Case for Blood-Based CNS Biomarkers

Victoria Akhiezer
April 22, 2026
NeuroDex and Stanford Researchers Publish First Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists Using Blood-Based Neuron-Derived Extracellular Vesicles
NeuroDex News

NeuroDex and Stanford Researchers Publish First Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists Using Blood-Based Neuron-Derived Extracellular Vesicles

Victoria Akhiezer
April 22, 2026

Posts pagination

1 2 3 4 5 6

Contact Us

Company

NeuroDex Inc

  • 22 Strathmore Road
  • Natick, MA US 01760
  • info@neurodex.co
Information
  • Terms & Conditions
  • Privacy Policy
  • Neurodex FAQ
Resources
  • Explanation Material
  • NeuroDex News
  • Blog
Back to top Drag
  • Home
  • About Us
    • Our Team
    • Our Labs
  • Our Tech
    • ExoSort Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • Pre-Clinical Services
    • Clinical Trial Services
  • Pressroom
    • NeuroDex News
    • Biotech Blog
    • Explanation Material
    • White Papers
    • Neurodex Brochures
  • Contact Us
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

More results...

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors